...the article is a total short biased butcher job. He claims the Phase 3 trial is really a Phase 2, and that all previous drugs for DME took 2 years of testing for approvals. What he fails to mention is that the FDA gave AMPE guidance in designing the trial that he so denigrates. He also states the obvious that no oral drug has ever been approved for DME.
The bottom line is that the results will speak for themselves, and if Optina shows indications of efficacy, the stock will soar well ahead of any final approval.
He lied so many times about Arena that he is responsible for literally peeling millions of market cap off the company with obvious, and reported slanderous lies only to profit with his buddies for the stocks decline, he now finds ARNA a "BUY" and does not mention his complete turnaround.
That guy Fraudstain is under extreme suspicion and someday we'll find him hanging